| cellular response to interferon beta | GO:0035458 | 21 | 1.000 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.997 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.980 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.969 | Human |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.961 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.905 | Human |
| regulation of viral genome replication | GO:0045069 | 13 | 0.905 | Human |
| negative regulation of viral genome replication | GO:0045071 | 10 | 0.900 | Human |
| regulation of multi organism process | GO:0043900 | 111 | 0.892 | Human |
| viral life cycle | GO:0019058 | 36 | 0.888 | Human |
| response to protozoan | GO:0001562 | 28 | 0.885 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.839 | |
| defense response to bacterium | GO:0042742 | 119 | 0.826 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.818 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.801 | |
| defense response to other organism | GO:0098542 | 197 | 0.793 | Human |
| response to interferon beta | GO:0035456 | 22 | 0.788 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.784 | Human |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.771 | |
| viral process | GO:0016032 | 41 | 0.760 | Human |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.749 | Human |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.741 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.726 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.716 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.707 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.691 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.677 | |
| isg15 protein conjugation | GO:0032020 | 4 | 0.662 | |
| innate immune response | GO:0045087 | 157 | 0.661 | Human |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.655 | Human |
| regulation of interferon alpha production | GO:0032647 | 5 | 0.624 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.622 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.621 | Human |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.573 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.572 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.567 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.545 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.527 | Human |
| activation of innate immune response | GO:0002218 | 56 | 0.522 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.520 | Mouse |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.502 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.487 | |
| mda 5 signaling pathway | GO:0039530 | 1 | 0.481 | |
| positive regulation of interferon beta production | GO:0032728 | 8 | 0.475 | |
| positive regulation of type i interferon production | GO:0032481 | 14 | 0.472 | |
| defense response to virus | GO:0051607 | 68 | 0.470 | Human |
| interferon beta production | GO:0032608 | 16 | 0.455 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.454 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.451 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.440 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.435 | Human Mouse |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.435 | |
| response to interferon gamma | GO:0034341 | 34 | 0.425 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.425 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.420 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.410 | |
| immune effector process | GO:0002252 | 321 | 0.402 | Human |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.401 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.397 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.378 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.369 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.354 | |
| regulation of protein transport | GO:0051223 | 163 | 0.341 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.334 | |
| negative regulation of defense response to virus | GO:0050687 | 6 | 0.329 | Human |
| type i interferon production | GO:0032606 | 29 | 0.325 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.324 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.323 | |
| regulation of myd88 dependent toll like receptor signaling pathway | GO:0034124 | 2 | 0.317 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.317 | |
| regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway | GO:0039531 | 2 | 0.302 | |
| pre mirna processing | GO:0031054 | 3 | 0.301 | |
| viral gene expression | GO:0019080 | 3 | 0.296 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.279 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.274 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.273 | |
| regulation of neutrophil mediated killing of gram negative bacterium | GO:0070951 | 1 | 0.269 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.263 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.262 | |
| negative regulation of interferon alpha production | GO:0032687 | 1 | 0.260 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.254 | |
| viral genome replication | GO:0019079 | 17 | 0.248 | Human |
| regulation of defense response | GO:0031347 | 233 | 0.245 | Human |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.242 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.240 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.228 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.223 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.218 | |
| regulation of type i interferon production | GO:0032479 | 22 | 0.214 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.212 | |
| response to type i interferon | GO:0034340 | 12 | 0.211 | Human |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.209 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.208 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.207 | |
| defense response to protozoan | GO:0042832 | 25 | 0.207 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.200 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.199 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.192 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.188 | Human |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.187 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.186 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.186 | |
| production of small rna involved in gene silencing by rna | GO:0070918 | 6 | 0.185 | |
| regulation of regulatory t cell differentiation | GO:0045589 | 7 | 0.182 | |
| viral transcription | GO:0019083 | 3 | 0.177 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.177 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.175 | |
| cellular response to lipid | GO:0071396 | 145 | 0.173 | |
| muscle tissue development | GO:0060537 | 308 | 0.173 | |
| protein ubiquitination | GO:0016567 | 171 | 0.169 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.168 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.163 | |
| t helper 17 cell lineage commitment | GO:0072540 | 4 | 0.163 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.160 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.155 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.153 | |
| negative regulation of viral release from host cell | GO:1902187 | 6 | 0.153 | |
| negative regulation of interferon beta production | GO:0032688 | 3 | 0.152 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.151 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.150 | |
| gtp catabolic process | GO:0006184 | 143 | 0.149 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.149 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.144 | |
| cytokine production | GO:0001816 | 319 | 0.144 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.140 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.139 | |
| positive regulation of t helper 2 cell cytokine production | GO:2000553 | 3 | 0.137 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.134 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.133 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.130 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.128 | |
| response to interferon alpha | GO:0035455 | 7 | 0.124 | |
| positive regulation of viral entry into host cell | GO:0046598 | 3 | 0.123 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.120 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.120 | |
| negative regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway | GO:0039532 | 2 | 0.118 | |
| negative regulation of rig i signaling pathway | GO:0039536 | 2 | 0.116 | |
| histone acetylation | GO:0016573 | 41 | 0.113 | |
| movement in host environment | GO:0052126 | 15 | 0.107 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.107 | |
| regulation of cd8 positive alpha beta t cell proliferation | GO:2000564 | 1 | 0.106 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.104 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.104 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.102 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.102 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.102 | |
| autophagy | GO:0006914 | 45 | 0.097 | |
| interferon alpha production | GO:0032607 | 7 | 0.097 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.095 | |
| skin development | GO:0043588 | 220 | 0.095 | |
| protein acylation | GO:0043543 | 64 | 0.094 | |
| t helper 17 cell differentiation | GO:0072539 | 7 | 0.094 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.093 | Human |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.093 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.084 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 7 | 0.083 | |
| negative regulation of response to biotic stimulus | GO:0002832 | 10 | 0.082 | Human |
| adhesion of symbiont to host | GO:0044406 | 8 | 0.081 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.079 | |
| protein import | GO:0017038 | 101 | 0.079 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.076 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.076 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.076 | |
| neutrophil mediated killing of gram negative bacterium | GO:0070945 | 4 | 0.075 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.074 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.074 | |
| response to dsrna | GO:0043331 | 30 | 0.074 | Human |
| hair follicle cell proliferation | GO:0071335 | 3 | 0.073 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.072 | |
| spleen development | GO:0048536 | 39 | 0.070 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.069 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.068 | |
| chromatin organization | GO:0006325 | 206 | 0.068 | |
| regulation of cell motility | GO:2000145 | 236 | 0.068 | |
| limb development | GO:0060173 | 166 | 0.066 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.066 | Human |
| gtp metabolic process | GO:0046039 | 144 | 0.065 | |
| cellular response to type i interferon | GO:0071357 | 10 | 0.065 | Human |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.063 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.062 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.061 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.060 | |
| limb morphogenesis | GO:0035108 | 149 | 0.060 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.060 | |
| rna catabolic process | GO:0006401 | 29 | 0.060 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.059 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.058 | |
| protein import into nucleus | GO:0006606 | 95 | 0.058 | |
| stem cell development | GO:0048864 | 219 | 0.058 | |
| positive regulation of myelination | GO:0031643 | 5 | 0.058 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.057 | |
| cardiac cell development | GO:0055006 | 41 | 0.056 | |
| regulation of protein localization | GO:0032880 | 231 | 0.056 | |
| hatching | GO:0035188 | 4 | 0.054 | |
| entry into host cell | GO:0030260 | 15 | 0.054 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.053 | |
| myotube differentiation | GO:0014902 | 105 | 0.051 | |
| positive regulation of neutrophil mediated killing of symbiont cell | GO:0070961 | 1 | 0.051 | |
| negative regulation of cytoplasmic transport | GO:1903650 | 29 | 0.049 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.046 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.046 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 3 | 0.046 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.046 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.045 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.044 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.044 | |
| muscle cell development | GO:0055001 | 133 | 0.044 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.044 | |
| macromolecule methylation | GO:0043414 | 120 | 0.044 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.043 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.043 | |
| regulation of t helper 1 cell cytokine production | GO:2000554 | 1 | 0.043 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.042 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.042 | |
| schwann cell differentiation | GO:0014037 | 26 | 0.042 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.042 | |
| cytoplasmic pattern recognition receptor signaling pathway | GO:0002753 | 10 | 0.041 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.041 | |
| spindle assembly | GO:0051225 | 13 | 0.041 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.041 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.041 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.041 | |
| gland development | GO:0048732 | 330 | 0.039 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.039 | |
| type 2 immune response | GO:0042092 | 23 | 0.037 | |
| zygote asymmetric cell division | GO:0010070 | 2 | 0.037 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.036 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.035 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.035 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.035 | |
| regulation of binding | GO:0051098 | 111 | 0.035 | Human |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.035 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.035 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.035 | |
| positive regulation of neutrophil mediated cytotoxicity | GO:0070960 | 1 | 0.034 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.034 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.034 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.033 | Human |
| stem cell differentiation | GO:0048863 | 268 | 0.033 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.033 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.033 | Human |
| negative regulation of protein ubiquitination | GO:0031397 | 19 | 0.033 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.033 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.033 | |
| organelle assembly | GO:0070925 | 177 | 0.032 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.032 | |
| atp metabolic process | GO:0046034 | 75 | 0.032 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.032 | |
| regulation of biomineral tissue development | GO:0070167 | 33 | 0.031 | |
| myotube cell development | GO:0014904 | 60 | 0.031 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.031 | |
| positive regulation of binding | GO:0051099 | 49 | 0.030 | |
| production of mirnas involved in gene silencing by mirna | GO:0035196 | 6 | 0.030 | |
| interferon gamma production | GO:0032609 | 67 | 0.030 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.030 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.030 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.030 | |
| regulation of toll like receptor 9 signaling pathway | GO:0034163 | 3 | 0.030 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.029 | |
| inflammatory response | GO:0006954 | 244 | 0.029 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.029 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.029 | |
| intracellular protein transport | GO:0006886 | 204 | 0.029 | Human |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.029 | |
| tooth mineralization | GO:0034505 | 9 | 0.029 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.029 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.029 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.028 | |
| regulation of neutrophil mediated killing of symbiont cell | GO:0070949 | 2 | 0.028 | |
| rna phosphodiester bond hydrolysis endonucleolytic | GO:0090502 | 10 | 0.028 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.028 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.028 | |
| regulation of cell migration | GO:0030334 | 219 | 0.028 | |
| negative regulation of intracellular protein transport | GO:0090317 | 27 | 0.028 | |
| neuronal action potential | GO:0019228 | 54 | 0.028 | |
| protein catabolic process | GO:0030163 | 221 | 0.028 | |
| syncytium formation | GO:0006949 | 43 | 0.028 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.027 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.027 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.027 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.027 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.027 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.026 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.026 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.026 | |
| lung development | GO:0030324 | 164 | 0.026 | |
| regulation of autophagy | GO:0010506 | 30 | 0.026 | |
| regulation of viral entry into host cell | GO:0046596 | 12 | 0.025 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.025 | |
| cation transport | GO:0006812 | 399 | 0.025 | |
| developmental maturation | GO:0021700 | 193 | 0.025 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.025 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.025 | |
| negative regulation of protein modification by small protein conjugation or removal | GO:1903321 | 20 | 0.025 | |
| epidermis development | GO:0008544 | 187 | 0.025 | |
| digestive system development | GO:0055123 | 200 | 0.025 | |
| activation of immune response | GO:0002253 | 138 | 0.025 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.025 | |
| protein oligomerization | GO:0051259 | 67 | 0.025 | |
| dna metabolic process | GO:0006259 | 303 | 0.025 | |
| skeletal system development | GO:0001501 | 356 | 0.024 | |
| interaction with host | GO:0051701 | 22 | 0.024 | Human |
| cellular homeostasis | GO:0019725 | 240 | 0.024 | |
| myd88 independent toll like receptor signaling pathway | GO:0002756 | 3 | 0.024 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.024 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.023 | |
| respiratory system development | GO:0060541 | 190 | 0.023 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.023 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.023 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.023 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.023 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.023 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.023 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.023 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.023 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.023 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.023 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.023 | |
| striated muscle cell development | GO:0055002 | 125 | 0.023 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.023 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.023 | |
| gene silencing | GO:0016458 | 38 | 0.023 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.023 | |
| single organism nuclear import | GO:1902593 | 95 | 0.023 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.022 | |
| atp catabolic process | GO:0006200 | 55 | 0.022 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.022 | |
| action potential | GO:0001508 | 78 | 0.022 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.022 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.022 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.022 | |
| forebrain development | GO:0030900 | 302 | 0.022 | |
| anion transport | GO:0006820 | 177 | 0.022 | |
| connective tissue development | GO:0061448 | 179 | 0.022 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.022 | |
| type i interferon biosynthetic process | GO:0045351 | 9 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.021 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.021 | |
| regulation of system process | GO:0044057 | 200 | 0.021 | |
| germ cell development | GO:0007281 | 185 | 0.021 | |
| inner ear receptor cell development | GO:0060119 | 39 | 0.021 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.021 | |
| transmembrane transport | GO:0055085 | 412 | 0.021 | |
| spinal cord development | GO:0021510 | 81 | 0.021 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.021 | |
| maintenance of location | GO:0051235 | 89 | 0.021 | |
| ossification | GO:0001503 | 216 | 0.021 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.021 | |
| cation homeostasis | GO:0055080 | 212 | 0.021 | |
| microtubule based process | GO:0007017 | 236 | 0.021 | |
| natural killer cell proliferation | GO:0001787 | 3 | 0.021 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.021 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.021 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.021 | |
| positive regulation of interleukin 12 production | GO:0032735 | 21 | 0.021 | |
| t cell differentiation | GO:0030217 | 174 | 0.021 | |
| protein methylation | GO:0006479 | 81 | 0.020 | |
| histone modification | GO:0016570 | 159 | 0.020 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.020 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.020 | Human |
| regulation of neutrophil mediated killing of fungus | GO:0070953 | 1 | 0.020 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.020 | |
| citrate metabolic process | GO:0006101 | 3 | 0.020 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.020 | |
| respiratory tube development | GO:0030323 | 167 | 0.020 | |
| endocytosis | GO:0006897 | 168 | 0.020 | |
| sensory perception | GO:0007600 | 245 | 0.020 | |
| methylation | GO:0032259 | 134 | 0.020 | |
| multicellular organism growth | GO:0035264 | 161 | 0.020 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.020 | |
| protein sumoylation | GO:0016925 | 14 | 0.020 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.019 | |
| cd4 positive or cd8 positive alpha beta t cell lineage commitment | GO:0043369 | 8 | 0.019 | |
| regulation of dna binding | GO:0051101 | 39 | 0.019 | |
| positive regulation of toll like receptor 9 signaling pathway | GO:0034165 | 2 | 0.019 | |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.019 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.019 | |
| protein alkylation | GO:0008213 | 81 | 0.019 | |
| appendage development | GO:0048736 | 166 | 0.019 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.019 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.019 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.019 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.019 | |
| adaptive immune response | GO:0002250 | 155 | 0.019 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.019 | |
| positive regulation of neutrophil mediated killing of fungus | GO:0070965 | 1 | 0.019 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.019 | |
| regulation of myelination | GO:0031641 | 20 | 0.019 | |
| spermatogenesis | GO:0007283 | 284 | 0.019 | |
| nerve development | GO:0021675 | 67 | 0.019 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.018 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.018 | |
| glial cell differentiation | GO:0010001 | 131 | 0.018 | |
| cell division | GO:0051301 | 120 | 0.018 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.018 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.018 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.018 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.018 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.018 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.018 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.018 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.018 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.017 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.017 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.017 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.017 | |
| regulation of interleukin 12 production | GO:0032655 | 30 | 0.017 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.017 | |
| mrna stabilization | GO:0048255 | 9 | 0.017 | |
| regulation of type 2 immune response | GO:0002828 | 18 | 0.017 | |
| gliogenesis | GO:0042063 | 141 | 0.017 | |
| negative regulation of interferon beta biosynthetic process | GO:0045358 | 1 | 0.017 | |
| angiogenesis | GO:0001525 | 201 | 0.017 | |
| negative regulation of schwann cell proliferation | GO:0010626 | 1 | 0.017 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.017 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.017 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.017 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.017 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.017 | Human |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.016 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.016 | |
| protein secretion | GO:0009306 | 111 | 0.016 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.016 | |
| mesenchyme development | GO:0060485 | 152 | 0.016 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.016 | |
| regulation of cell activation | GO:0050865 | 289 | 0.016 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.016 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.016 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.016 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.016 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.016 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.016 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.016 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.015 | |
| leukocyte migration | GO:0050900 | 124 | 0.015 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.015 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.015 | |
| telencephalon development | GO:0021537 | 186 | 0.015 | |
| negative regulation of growth | GO:0045926 | 99 | 0.015 | |
| renal tubule development | GO:0061326 | 87 | 0.015 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.015 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.015 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.015 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.015 | Human |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.015 | |
| negative regulation of regulatory t cell differentiation | GO:0045590 | 2 | 0.015 | |
| chemokine production | GO:0032602 | 34 | 0.015 | |
| cerebral cortex development | GO:0021987 | 86 | 0.015 | |
| regulation of protein binding | GO:0043393 | 60 | 0.015 | Human |
| regulation of ossification | GO:0030278 | 112 | 0.015 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.015 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.015 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.015 | |
| pallium development | GO:0021543 | 120 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.015 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.015 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.015 | |
| neutrophil mediated killing of fungus | GO:0070947 | 3 | 0.015 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.015 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.015 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.015 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.015 | |
| negative regulation of gliogenesis | GO:0014014 | 23 | 0.014 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.014 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.014 | |
| rna interference | GO:0016246 | 2 | 0.014 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.014 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.014 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.014 | |
| cellular response to dsrna | GO:0071359 | 12 | 0.014 | Human |
| rna phosphodiester bond hydrolysis | GO:0090501 | 19 | 0.014 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.014 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.014 | |
| heart morphogenesis | GO:0003007 | 178 | 0.014 | |
| axon ensheathment | GO:0008366 | 76 | 0.014 | |
| protein maturation | GO:0051604 | 176 | 0.014 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.014 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.014 | |
| pyroptosis | GO:0070269 | 8 | 0.014 | |
| viral release from host cell | GO:0019076 | 6 | 0.014 | |
| regulation of secretion | GO:0051046 | 274 | 0.013 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.013 | |
| interferon gamma mediated signaling pathway | GO:0060333 | 5 | 0.013 | |
| circadian rhythm | GO:0007623 | 114 | 0.013 | |
| male gamete generation | GO:0048232 | 285 | 0.013 | |
| regulation of neuron death | GO:1901214 | 134 | 0.013 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.013 | |
| protein localization to organelle | GO:0033365 | 185 | 0.013 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.013 | |
| positive regulation of killing of cells of other organism | GO:0051712 | 3 | 0.013 | |
| asymmetric cell division | GO:0008356 | 8 | 0.013 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.013 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.013 | |
| immunoglobulin production | GO:0002377 | 73 | 0.013 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.013 | |
